The global autologous cell therapy market is expected to grow from USD 9.29 billion in 2019 to USD 42.68 billion by 2027, at a CAGR of 21.00% during the forecast period 2020-2027.
Autologous cell therapy (ACT) is an innovative therapeutic intervention that utilizes an individual’s cells, that are cultured and developed outside the body, and reintroduced into the donor. The benefits of such an approach involve the minimization of risks from systemic immunological reactions and bio-incompatibility. Also, disease transmission connected with cells or grafts that are not cultivated from the individual gives added benefits. So far, this kind of treatment has been utilized successfully to aid wound healing, counteract chronic inflammation, bioengineer skin substitutes, treat burns and pressure ulcers, and enhance postoperative healing.Autologous cell therapy technology (a form of regenerative cell therapy) changes treatments by launching various new therapies. Its range is broad and promising for the future despite difficulties. It is a new therapeutic platform proliferating in the field of regenerative medication. It is acknowledged as an effective and safer technology. Autologous stem cell therapy technology has already been successful in the treatment of cosmetic surgeries, skin substitutes, prostate cancer, skin burns, wound healing and pressure ulcers, etc.The treatment is recognized as a safer and efficient technology compared with the existing transplant technologies, such as xenotransplants and allogeneic. Autologous transplants promote in mitigation of risks associated with bio-incompatibility, disease transmission, and immunological reactions. The rising frequencies of mortality and morbidity of cancer and ample funding from the government, as well as many private facilities in order to restrict the growth of cancer, has currently made the procedure for cancer the topmost priority across the globe. The growth of widespread diseases and a massive number of stem cell helpers are the crucial factors driving the demand of the market. Stem cells have the potential to advance into many types of cells in the body during the early stage of life. And it also serves as an internal repairing system. Hence the number of therapies based on stem cells is comparatively higher.
This study delivers a comprehensive analysis of sources, applications and regions.The source segment includesbone marrow, epidermis, mesenchymal stem cells, hematopoietic stem cells and chondrocytes.The bone marrow segment held the highest share in the autologous cell therapy market in 2019. It is due to most of the hematopoietic and mesenchyme stem cells are retrieved from the bone marrow.The application segment includes cancer, neurodegenerative diseases, wound healing, orthopedic, cardiovascular diseases and autoimmune diseases.The cancer segment held the highest share in the autologous cell therapy market in 2019. Autologous cell therapy is a system that utilizes restored blood-forming stem cells in patients who have had theirs damaged by the high dosage of radiation or chemotherapy.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.North America held the largest share in the autologous cell therapy market in 2019. The region has access to the latest advanced technologies, substantial economic growth, and significant investment by the private and public sectors. Other factors driving the market in the region are secure approval for clinical trials, the availability of state-of-the-art research infrastructure, and an increase in research and development initiatives in order to develop therapeutic options for chronic diseases.
Some of the notable players in the global autologous cell therapy market areBayer AG, Daiichi Sankyo Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., HolostemTerapieAvanzateSrl, Vericel Corp., Osiris Therapeutics Inc., Brainstorm Cell Therapeutics Inc., Sumitomo Chemical Co. Ltd., and FUJIFILM Holdings Corp.
This study forecasts revenue growth at global, regional, and country levels from 2020 to 2027. Fior Markets has segmented the market based on below-mentioned segments:
Global Autologous Cell Therapy Market Analysis And Forecast, By Source
Global Autologous Cell Therapy Market Analysis And Forecast, By Application
Global Autologous Cell Therapy Market Analysis And Forecast, By Regional Analysis
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Source
4.3.2. Market Attractiveness Analysis By Application
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increasing incidence of chronic diseases
5.2.2. Increase in the population undergoing severe conditions
5.2.3. Moderate risk of complexities connected with autologous treatment
5.2.4. Affordability, enhanced survival rate of patients
5.3. Opportunities
5.3.1. Investments and endowments done to the research facilities by the private and public sectors
5.4. Challenges
5.4.1. The cost of the processing
6. Global Autologous Cell Therapy Market Analysis and Forecast, By Source
6.1. Segment Overview
6.2. Bone Marrow
6.3. Epidermis
6.4. Mesenchymal Stem Cells
6.5. Hematopoietic Stem Cells
6.6. Chondrocytes
7. Global Autologous Cell Therapy Market Analysis and Forecast, By Application
7.1. Segment Overview
7.2. Cancer
7.3. Neurodegenerative Diseases
7.4. Wound Healing
7.5. Orthopedic
7.6. Cardiovascular Diseases
7.7. Autoimmune Diseases
8. Global Autologous Cell Therapy Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Autologous Cell Therapy Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Autologous Cell Therapy Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Application Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Bayer AG
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Source Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Daiichi Sankyo Co. Ltd.
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Source Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Takeda Pharmaceutical Co. Ltd.
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Source Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Teva Pharmaceutical Industries Ltd.
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Source Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. HolostemTerapieAvanzateSrl
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Source Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Vericel Corp.
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Source Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Osiris Therapeutics Inc.
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Source Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Brainstorm Cell Therapeutics Inc.
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Source Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Sumitomo Chemical Co. Ltd.
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Source Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. FUJIFILM Holdings Corp
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Source Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
List of Table
1. Global Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
2. GlobalBone Marrow, Autologous Cell Therapy Market, By Region, 2017-2027 (USD Billion) (K Units)
3. Global Epidermis, Autologous Cell Therapy Market, By Region, 2017-2027 (USD Billion) (K Units)
4. Global Mesenchymal Stem Cells, Autologous Cell Therapy Market, By Region, 2017-2027 (USD Billion) (K Units)
5. GlobalHematopoietic Stem Cells, Autologous Cell Therapy Market, By Region, 2017-2027 (USD Billion) (K Units)
6. GlobalChondrocytes, Autologous Cell Therapy Market, By Region, 2017-2027 (USD Billion) (K Units)
7. Global Autologous Cell Therapy Market, ByApplication, 2017-2027 (USD Billion) (K Units)
8. GlobalCancer, Autologous Cell Therapy Market, By Region, 2017-2027 (USD Billion) (K Units)
9. Global Neurodegenerative Diseases, Autologous Cell Therapy Market, By Region, 2017-2027 (USD Billion) (K Units)
10. Global Wound Healing, Autologous Cell Therapy Market, By Region, 2017-2027 (USD Billion) (K Units)
11. GlobalOrthopedic, Autologous Cell Therapy Market, By Region, 2017-2027 (USD Billion) (K Units)
12. GlobalCardiovascular Diseases, Autologous Cell Therapy Market, By Region, 2017-2027 (USD Billion) (K Units)
13. GlobalAutoimmune Diseases, Autologous Cell Therapy Market, By Region, 2017-2027 (USD Billion) (K Units)
14. North America Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
15. North America Autologous Cell Therapy Market, ByApplication, 2017-2027 (USD Billion) (K Units)
16. U.S. Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
17. U.S. Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
18. Canada Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
19. Canada Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
20. Mexico Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
21. Mexico Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
22. Europe Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
23. Europe Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
24. Germany Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
25. Germany Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
26. France Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
27. France Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
28. U.K. Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
29. U.K. Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
30. Italy Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
31. Italy Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
32. Spain Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
33. Spain Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
34. Asia Pacific Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
35. Asia Pacific Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
36. Japan Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
37. Japan Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
38. China Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
39. China Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
40. India Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
41. India Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
42. South America Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
43. South America Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
44. Brazil Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
45. Brazil Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
46. Middle East and Africa Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
47. Middle East and Africa Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
48. UAE Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
49. UAE Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
50. South Africa Autologous Cell Therapy Market, By Source, 2017-2027 (USD Billion) (K Units)
51. South Africa Autologous Cell Therapy Market, By Application, 2017-2027 (USD Billion) (K Units)
List of Figures
1. Global Autologous Cell Therapy Market Segmentation
2. Global Autologous Cell Therapy Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Autologous Cell Therapy Market Attractiveness Analysis by Source
9. Global Autologous Cell Therapy Market Attractiveness Analysis by Application
10. Global Autologous Cell Therapy MarketAttractiveness Analysis by Region
11. Global Autologous Cell Therapy Market: Dynamics
12. Global Autologous Cell Therapy Market Share by Source(2020 & 2027)
13. Global Autologous Cell Therapy Market Share by Application (2020 & 2027)
14. Global Autologous Cell Therapy Market Share by Regions (2020 & 2027)
15. Global Autologous Cell Therapy Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.